The Journal of Immunology, Vol 146, Issue 7 2324-2330, Copyright © 1991 by American Association of Immunologists

ARTICLES

Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q

HX Jiang, JN Siegel and H Gewurz
Department of Immunology/Microbiology, Rush Medical College, Chicago, IL 60612.

Ligand-complexed C-reactive protein (CRP), like aggregated or complexed IgG, can react with C1q and activate the classical C pathway. Whereas IgG is known to bind to the globular region and not to the collagen- like region (CLR) of C1q, the site of interaction of C1q with CRP has not been defined. CRP-trimers were prepared by cross-linking and found to bind to C1q and to activate the C system. Heat-aggregated IgG (Agg- IgG) did not block the binding of CRP-trimers to C1q, nor did CRP- trimers block binding of Agg-IgG to C1q, suggesting that CRP and IgG bind at different sites. ELISA and Western blot analysis showed that CRP-trimers bound to the CLR, whereas Agg-IgG bound only to the globular region; similarly, anti-CLR mAb inhibited binding of CRP- trimers to C1q whereas anti-globular region mAb did not. Reactivity with CRP-trimers as well as with Agg-IgG was retained after reduction/alkylation and SDS treatment of C1q. A group of 22 anti-CRP mAb directed against at least six distinct native-CRP epitopes and eight distinct neo-CRP epitopes was tested for ability to inhibit the CRP-CLR interaction; one mAb, anti-native CRP mAb 8D8, with strong inhibitory activity was identified. Fab' of 8D8 blocked binding of CRP- trimers to intact C1q as well as CLR, and also inhibited CRP (CRP- trimers and CRP-protamine complexes) induced C activation, but had no effect on C1q binding or C activation by Agg-IgG. These results indicate that a conformation-determined region on CRP binds to a sequence-determined region on the CLR of C1q in an interaction which leads to C activation. Anti-CRP and anti-C1q mAb that specifically inhibit this interaction are described.

This article has been cited by other articles:

				J. Li, D. T. Glover, A. J. Szalai, S. K. Hollingshead, and D. E. Briles PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement Activation Infect. Immun., December 1, 2007; 75(12): 5877 - 5885. [Abstract] [Full Text] [PDF]

				S.-R. Ji, Y. Wu, L. A. Potempa, Y.-H. Liang, and J. Zhao Effect of Modified C-Reactive Protein on Complement Activation: A Possible Complement Regulatory Role of Modified or Monomeric C-Reactive Protein in Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 935 - 941. [Abstract] [Full Text] [PDF]

				F. D. G. McGrath, M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region. J. Immunol., March 1, 2006; 176(5): 2950 - 2957. [Abstract] [Full Text] [PDF]

				P. Tacnet-Delorme, S. Chevallier, and G. J. Arlaud {beta}-Amyloid Fibrils Activate the C1 Complex of Complement Under Physiological Conditions: Evidence for a Binding Site for A{beta} on the C1q Globular Regions J. Immunol., December 1, 2001; 167(11): 6374 - 6381. [Abstract] [Full Text] [PDF]

				A. Agrawal, A. K. Shrive, T. J. Greenhough, and J. E. Volanakis Topology and Structure of the C1q-Binding Site on C-Reactive Protein J. Immunol., March 15, 2001; 166(6): 3998 - 4004. [Abstract] [Full Text] [PDF]

				D. Gershov, S. Kim, N. Brot, and K. B. Elkon C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response: Implications for Systemic Autoimmunity J. Exp. Med., November 6, 2000; 192(9): 1353 - 1364. [Abstract] [Full Text] [PDF]

				B. Bottazzi, V. Vouret-Craviari, A. Bastone, L. De Gioia, C. Matteucci, G. Peri, F. Spreafico, M. Pausa, C. D'Ettorre, E. Gianazza, et al. Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3. SIMILARITIES AND DIFFERENCES WITH THE SHORT PENTRAXINS C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT J. Biol. Chem., December 26, 1997; 272(52): 32817 - 32823. [Abstract] [Full Text] [PDF]

				P. B. Armstrong, S. Swarnakar, S. Srimal, S. Misquith, E. A. Hahn, R. T. Aimes, and J. P. Quigley A Cytolytic Function for a Sialic Acid-binding Lectin That Is a Member of the Pentraxin Family of Proteins J. Biol. Chem., June 21, 1996; 271(25): 14717 - 14721. [Abstract] [Full Text] [PDF]

				K. Zahedi and K. Zahedi Characterization of the Binding of Serum Amyloid P to Type IV Collagen J. Biol. Chem., June 21, 1996; 271(25): 14897 - 14902. [Abstract] [Full Text] [PDF]

				V. Fremeaux-Bacchi, L. Weiss, C. Demouchy, J. Blouin, and M. Kazatchkine Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus Lupus, June 1, 1996; 5(3): 216 - 220. [Abstract] [PDF]